Yes, appreciate your interpretation of those sources/articles. My interpretation of the content leads me to a different conclusion(s). From what I gather, the difficulty in enrolling trial subjects is limited to the Combo Trial's criteria which will not be a factor in the Mono Trial or in adoption once approval is secured. That said, I can understand your viewpoint, but heartily disagree with it.
News 
Market Data 
Discover 
